Stylianos Lefkopoulos (he/him)
@slefkopoulos.bsky.social did:plc:mz4nog7rtfpvxjkjk567dsp7
Senior Editor at @natcellbio.nature.com: #stemcells & #embryo development #disease | proud scientist | 🏳️🌈 gender fluid, antisexist, liberal | 🍫 📚 🐶 🧑🍳 🌱 |📍Berlin | views are his own | call him Stelios
En Bluesky desde el
- Seguidores
- 3.287
- Siguiendo
- 361
- Posts
- 231
- Días en rankings
- 0
Resumen
Stylianos Lefkopoulos (he/him) (@slefkopoulos.bsky.social) es un usuario de Bluesky que se unió el 14 noviembre 2024. Tiene 3.287 seguidores, sigue a 361 cuentas y ha publicado 231 posts.
Apariciones en rankings
Los mejores días en que los posts de esta cuenta entraron en la lista diaria de Debya.
Esta cuenta aún no ha aparecido en un ranking diario.
Posts que le gustaron recientemente
Me gusta públicos de la red Bluesky.
It's already been 20 years since Kazutoshi Takahashi and Shinya Yamanaka published their landmark paper on iPSCs in Cell. Amazing how a single publication could spark an entire field! #iPSCell buff.ly/sRzPzBr
Ver postThis is a very cool paper for those of us studying pregnancy and cancer. Of course, implantation needs to be a dialogue between the decidua and the blastocyst, but now we know some of the sentences they use to talk to each other.....
Ver postIt was a brilliant opportunity to be able to comment on this latest assembloid story ! Exciting to see the field moving forward !
Ver postMissed highlighting my choice last week in @science.org Elevated contractility drives implantation failure in mouse embryos from aged females www.nature.com/articles/s41...
Ver postThe transformative concept of cellular reprogramming is now being applied for in vivo cancer immunotherapy. How might the next 20 years expand reprogramming approaches within the tumor microenvironment? Exciting times ahead! #iPSC #CellularReprogramming #CancerImmunotherapy
Ver post
Cuentas que bloquea
En Bluesky los bloqueos son registros públicos.
